Jayme Locke, MD MARCO ISLAND, Fla.—The transplant community may want to rethink the importance of HLA mismatches when considering live donor kidney transplants, according to new data presented here at ...
Umbilical cord blood is used as a source of hematopoietic stem cells for patients with blood cancers and other life-threatening disorders when matched donors are unavailable. Umbilical cord blood ...
Umbilical cord blood transplantation has expanded treatment options for patients with blood cancers and other life-threatening hematological disorders, especially when a fully matched donor cannot be ...
Analysis of a HLA-DPB1 regulatory region variant has shed light on the risk of acute graft-versus-host disease (GVHD) in patients undergoing haematopoietic cell transplantation from an unrelated donor ...
Post-Transplant Cyclophosphamide–Based Graft-Versus-Host Disease Prophylaxis Attenuates Disparity in Outcomes Between Use of Matched or Mismatched Unrelated Donors The study included 17,292 unrelated ...
Analyses of two large stem-cell transplant registries yielded conflicting results about the effect of post-transplant cyclophosphamide (PTCy) for graft-versus-host disease (GVHD) prophylaxis on the ...
Please provide your email address to receive an email when new articles are posted on . Healio spoke with Heather Stefanski, MD, PhD, for a three-part video series about trends in the field of bone ...
MINNEAPOLIS, Feb. 04, 2026 (GLOBE NEWSWIRE) -- NMDPSM, a global nonprofit leader in cell therapy, and CIBMTR® (Center for International Blood and Marrow Transplant Research®) will present research ...
A commonly inherited gene deletion can increase the likelihood of immune complications following bone marrow transplantation, an international team of researchers reports in the November 22 advance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results